Original Research

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)

Gerd Bönner, Bernhard Landers, Peter Bramlage

Vascular Health and Risk Management 2011, 7:85-95

Published Date: 17 February 2011